[go: up one dir, main page]

AU1698997A - Tocolytic oxytocin receptor antagonists - Google Patents

Tocolytic oxytocin receptor antagonists

Info

Publication number
AU1698997A
AU1698997A AU16989/97A AU1698997A AU1698997A AU 1698997 A AU1698997 A AU 1698997A AU 16989/97 A AU16989/97 A AU 16989/97A AU 1698997 A AU1698997 A AU 1698997A AU 1698997 A AU1698997 A AU 1698997A
Authority
AU
Australia
Prior art keywords
receptor antagonists
oxytocin receptor
tocolytic oxytocin
tocolytic
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16989/97A
Inventor
Roger M. Friedinger
Debra S. Perlow
Michelle A. Sparks
Peter D. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605701.3A external-priority patent/GB9605701D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU1698997A publication Critical patent/AU1698997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16989/97A 1996-01-16 1997-01-13 Tocolytic oxytocin receptor antagonists Abandoned AU1698997A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1003496P 1996-01-16 1996-01-16
US010034 1996-01-16
GB9605701 1996-03-19
GBGB9605701.3A GB9605701D0 (en) 1996-03-19 1996-03-19 Tocolytic oxytocin receptor antagonists
PCT/US1997/000571 WO1997025992A1 (en) 1996-01-16 1997-01-13 Tocolytic oxytocin receptor antagonists

Publications (1)

Publication Number Publication Date
AU1698997A true AU1698997A (en) 1997-08-11

Family

ID=26308952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16989/97A Abandoned AU1698997A (en) 1996-01-16 1997-01-13 Tocolytic oxytocin receptor antagonists

Country Status (2)

Country Link
AU (1) AU1698997A (en)
WO (1) WO1997025992A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0805681A4 (en) * 1995-01-24 1998-05-06 Merck & Co Inc TOCOLYTIC ANTAGONISTS OF OXYTOCIN RECEPTORS
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7064120B2 (en) 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
ES2193875B2 (en) 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS.
JP4697962B2 (en) 2003-02-13 2011-06-08 ウェルスタット セラピューティクス コーポレイション Compounds for the treatment of metabolic disorders
KR20080089453A (en) 2006-01-25 2008-10-06 웰스태트 테러퓨틱스 코포레이션 Compounds for the treatment of metabolic disorders
US7820721B2 (en) 2006-01-25 2010-10-26 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
KR20080097418A (en) 2006-02-02 2008-11-05 웰스태트 테러퓨틱스 코포레이션 Compounds for the treatment of metabolic disorders
ES2374952T3 (en) 2006-12-06 2012-02-23 Glaxosmithkline Llc BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS.
MX344264B (en) 2009-02-13 2016-12-09 Boehringer Ingelheim Int Gmbh * SGLT-2 INHIBITOR FOR THE TREATMENT OF MELLITUS DIABETES TYPE 1, MELLITUS DIABETES TYPE 2, TOLERANCE DETERIORATED TO GLUCOSE OR HYPERGLUCEMIA.
HK1215398A1 (en) 2013-04-05 2016-08-26 勃林格殷格翰国际有限公司 Therapeutic uses of empagliflozin
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
PT2986304T (en) 2013-04-18 2022-02-25 Boehringer Ingelheim Int Pharmaceutical composition, methods for treating and uses thereof
MA46742A (en) 2016-11-10 2019-09-18 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344945A (en) * 1980-03-10 1982-08-17 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives

Also Published As

Publication number Publication date
WO1997025992A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
AU3633997A (en) Chemokine receptor antagonists
AU1698997A (en) Tocolytic oxytocin receptor antagonists
AU1765695A (en) Non-peptidyl tachykinin receptor antagonists
AU1842995A (en) N-acylpiperidine tachykinin antagonists
AU4343796A (en) Tachykinin antagonists
AU3579897A (en) Fibrinogen receptor antagonists
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU4746297A (en) Vitronectin receptor antagonists
AU3899997A (en) Muscarinic antagonists
AU7692996A (en) Receptor antagonists
AU2242197A (en) Benzimidzolyl neuropeptide y receptor antagonists
IL135797A0 (en) Thrombin receptor antagonists
AU8673198A (en) Il-8 receptor antagonists
AU6856796A (en) Des-arg9-bk antagonists
AU4763896A (en) Tocolytic oxytocin receptor antagonists
AU5764298A (en) Tachykinin antagonists
AU4999897A (en) Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
AU6435098A (en) Il-8 receptor antagonists
GB9813103D0 (en) Tocolytic oxytocin receptor antagonists
AU1574995A (en) Tachykinins antagonists
AU6826598A (en) Endothelin-receptor antagonists
GB9704025D0 (en) Tocolytic oxytocin receptor antagonists
AU6826498A (en) Endotholin receptor antagonists
AU5239898A (en) Phenyl spiroethercycloalkyl tachykinin receptor antagonists
AU6826698A (en) Endothelin receptor antagonists